Offer - Urjas Oil for just ₹ 1 X
Imatinib, a prescription drug, is manufactured in various forms such as Tablet. Chronic Myelogenous Leukemia are some of its major therapeutic uses. Other than this, Imatinib has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Imatinib. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Imatinib can also lead to other problems, which have been listed below. These side effects of Imatinib are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Imatinib is Severe for pregnant women and Moderate for women who are breastfeeding. It is important to know if Imatinib has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Imatinib related warnings section.
The section on Imatinib contraindications lists all such conditions.
Besides this, Imatinib may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Imatinib is not safe while driving, and is is not addictive in nature.
Imatinib is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
2 - 12 years (Child) |
|
13 - 18 years (Adolescent) |
|
Is the use of Imatinib safe for pregnant women?
Imatinib should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Imatinib safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Imatinib. Immediately discontinue Imatinib if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Imatinib on the Kidneys?
Imatinib can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Imatinib on the Liver?
Imatinib has very mild side effects on the liver.
What is the effect of Imatinib on the Heart?
There may be an adverse effect on the heart after taking Imatinib. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Imatinib should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Imatinib unless your doctor advises you to do so -
Is this Imatinib habit forming or addictive?
No, you will not get addicted to Imatinib.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Imatinib. So it is best to avoid driving.
Is it safe?
Yes, but take Imatinib only as per medical advice.
Is it able to treat mental disorders?
Imatinib is unable to treat or cure mental disorders.
Interaction between Food and Imatinib
You can take Imatinib with food.
Interaction between Alcohol and Imatinib
Information about the interaction of Imatinib and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gleevec (imatinib mesylate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 674-676
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869